Trial NCT04646590
Publication Dai L, N Engl J Med, 2022
Primary outcome on the report: Real-time PCR–confirmed symptomatic Covid-19 occurring at least 7 days after the third dose.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.